Post-Market Observation Study of Intra-renal Drug Delivery (PROVIDE)

TerminatedOBSERVATIONAL
Timeline

Start Date

February 28, 2010

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Acute Kidney InjuryAcute Renal FailureRenal Failure Chronic Contrast InducedChronic Kidney Disease
Interventions
DEVICE

Benephit catheter for Targeted Renal Therapy

Local physician-specified agent delivery to the kidneys bilaterally via the renal arteries using the Benephit infusion system.

Trial Locations (15)

17201

Chambersburg Hospital, Chambersburg

23298

Virginia Commonwealth University Medical Center, Richmond

33025

HealthwoRx South Florida Research Solutions, Miramar

33176

Baptist Cardiac & Vascular Institute, Miami

41101

King's Daughters Medical Center, Ashland

42101

Graves Gilbert Clinic, Bowling Green

Sahetya Medical Institute, Bowling Green

Western Kentucky Heart and Lung, Bowling Green

University of Maryland Medical Center, Baltimore

46321

Cardiology Associates of NW Indiana, Munster

48236

St. John Hospital & Medical Center, Detroit

52803

Midwest Cardiovascular Research Foundation, Davenport

63301

St. Joseph Health Center, Saint Charles

83221

Bingham Memorial Hospital, Blackfoot

84041

Utah Cardiology PC, Layton

Sponsors
All Listed Sponsors
lead

Angiodynamics, Inc.

INDUSTRY